IMMUTEP Ltd — Investor Relations & Filings
Immutep Ltd. is a late clinical-stage biotechnology company developing novel immunotherapies for cancer and autoimmune diseases. As a pioneer in its field, the company focuses on therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system. Immutep's diversified portfolio is designed to harness LAG-3 to either stimulate the immune response to fight cancer or modulate it to combat autoimmune diseases. Its lead product candidate is eftilagimod alfa, a soluble LAG-3 fusion protein under investigation in multiple oncology trials. The company maintains a pipeline of several clinical-stage assets targeting areas of high unmet medical need.
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 39615357 | 6-K - IMMUTEP Ltd (0001506184) (Filer) | 2026-05-01 | English | ||
|
2025
14 filings
| |||||
| 12405217 | 6-K | 2025-12-22 | English | ||
| 12405218 | 6-K | 2025-12-16 | English | ||
| 12405219 | FORM 6-K | 2025-12-09 | English | ||
| 12405220 | FORM 6-K | 2025-12-03 | English | ||
| 12405221 | FORM 6-K | 2025-11-14 | English | ||
| 12405223 | 6-K | 2025-11-04 | English | ||
| 12405222 | 6-K | 2025-10-30 | English | ||
| 12405224 | 20-F | 2025-10-24 | English | ||
| 12405225 | 6-K | 2025-10-21 | English | ||
| 12405228 | 6-K | 2025-10-21 | English | ||
| 12405226 | 6-K | 2025-10-14 | English | ||
| 12405227 | 6-K | 2025-10-09 | English | ||
| 12405231 | 6-K | 2025-09-23 | English | ||
| 12405229 | 6-K | 2025-09-03 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
NANOVIRICIDES, INC.
Clinical-stage biopharma developing broad-spectrum, nanomed…
|
NNVC | US | Professional, scientific and te… |
|
Natcore Technology Inc.
R&D entity using nanotechnology to improve solar cell effic…
|
NTCXF | CA | Professional, scientific and te… |
|
Nautilus Biotechnology, Inc.
Develops a proteome analysis platform to quantify proteins …
|
NAUT | US | Professional, scientific and te… |
|
NeoImmuneTech, Inc.
A clinical-stage biopharma developing T cell-focused immuno…
|
950220 | US | Professional, scientific and te… |
|
Neovacs
Biotech firm developing immunotherapies and investing in Bi…
|
ALNEV | FR | Professional, scientific and te… |
|
NervGen Pharma Corp.
Clinical-stage biotech developing treatments to promote ner…
|
NGEN | CA | Professional, scientific and te… |
|
NEUREN PHARMACEUTICALS LIMITED
Develops innovative therapies for rare neurodevelopmental d…
|
NEU | NZ | Professional, scientific and te… |
|
NEURIZON THERAPEUTICS LIMITED
Clinical-stage developer of mTOR modulators for ALS and neu…
|
NUZ | AU | Professional, scientific and te… |
|
NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
Develops peptide-based therapeutics for neurodegenerative a…
|
NSB | AU | Professional, scientific and te… |
|
NEUROTECH INTERNATIONAL LIMITED
Clinical-stage biopharmaceutical company developing pediatr…
|
NTI | AU | Professional, scientific and te… |
IMMUTEP Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33450/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33450 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33450 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33450 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33450}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IMMUTEP Ltd (id: 33450)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.